Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/31/2021 40 44
Tetrandrine Potential treatment - pre-clinical evidence Natural product Antiviral Mar/23/2021 4 0
Remdesivir Approved by FDA Experimental Antiviral Mar/23/2021 60 4
Nafamostat mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/20/2021 12 0
Favipiravir Approved for COVID-19 treatment (China, India, Russia) Used to treat other disease Antiviral Mar/19/2021 23 7
Clofazimine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/16/2021 3 0
Indinavir Potential treatment - theoretical effect Used to treat other disease Antiviral Mar/07/2021 7 1
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Mar/01/2021 26 15
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Feb/23/2021 34 4
Atazanavir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/26/2020 6 1